FDA inspection
Shilpa Medicare Limited: FDA inspection ending Nov 9, 2023
FDA inspection 1224070 · Polepally, Jadcherla
Key facts
| Inspection ID | 1224070 |
|---|---|
| Firm | Shilpa Medicare Limited |
| FEI number | 3009876430 |
| Address | S-20 To S-26, Pharm. Formulation Sez, Tsiic, Green Industrial Park |
| City | Polepally, Jadcherla |
| Fiscal year | 2024 |
| Inspection end date | Nov 9, 2023 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data